About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in San Francisco | 5,203 Studies Near You

Clinical TrialsSan Francisco

Clinical Trials in San Francisco

Discover 5,203 clinical trials near San Francisco, California. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2461-2480 of 5,203 trials

TerminatedCoronary Artery Revascularization in DiabetesThis is a randomized, multi-site, clinical trial comparing percutaneous coronary stenting (PCI) with drug eluding stents to coronary bypass for angiographically significant…NCT00326196·Birmingham, Alabama and 25 others CompletedUnderstanding the Role of Genes and Biomarkers in the Inflammation and Blood Clotting Process in Children With Acute Lung InjuryAcute lung injury (ALI)/Acute Respiratory Distress Syndrome (ARDS) is a severe lung condition that causes respiratory failure.NCT00605527·Fresno, California and 4 others

Find Trials by Condition in San Francisco

Breast Cancerin San Francisco Lung Cancerin San Francisco Prostate Cancerin San Francisco Colorectal Cancerin San Francisco Melanomain San Francisco Leukemiain San Francisco Lymphomain San Francisco Pancreatic Cancerin San Francisco Ovarian Cancerin San Francisco Brain Cancerin San Francisco

Data from ClinicalTrials.govTerms

Active not recruitingObinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular LymphomaThis phase II trial studies how well obinutuzumab, ibrutinib, and venetoclax work in treating patients with previously untreated stage II-IV follicular lymphoma.NCT04450173·Fresno, California and 3 others

CompletedEvaluating the Safety and Pharmacokinetics of Raltegravir in InfantsThe purpose of this study was to determine the washout pharmacokinetics (PK) and safety of in utero/intrapartum exposure to maternal raltegravir (RAL) in infants born to pregnant…NCT01828073·La Jolla, California and 18 others

Active not recruitingPercutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)This is a prospective, multicenter, open-label, randomized trial comparing mitral valve (MV) transcatheter edge-to-edge repair (TEER) to surgical repair (1:1 ratio) in patients…NCT05051033·Los Angeles, California and 66 others

CompletedAirway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid TreatmentThere are new, very sensitive methods for detecting bacteria.NCT01537133·San Francisco, California and 8 others

CompletedEverolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or AnastrozoleThere are no treatments specifically approved after recurrence or progression on a non steroidal aromatase inhibitors (NSAI).NCT00863655·Chandler, Arizona and 199 others

CompletedSafety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular CarcinomaThis study is an open-label, multi-center, phase 1, dose escalation study with a phase 2 expansion cohort to determine the safety, pharmacokinetics and preliminary anti-tumor…NCT02191878·Tucson, Arizona and 14 others

CompletedFolic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)The purpose of this randomized clinical trial is to determine if lowering homocysteine levels in renal transplant recipients with a multivitamin will reduce the occurrence of…NCT00064753·Birmingham, Alabama and 29 others

CompletedComparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)Scleroderma is a rare, long-term autoimmune disease in which normal tissue is replaced with dense, thick fibrous tissue.NCT00883129·Los Angeles, California and 13 others

TerminatedA Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)Some human epidermal growth factor receptor 2 (HER-2) breast cancer patients do not respond or become resistant to current treatment.NCT03248492·Anchorage, Alaska and 98 others

CompletedCombination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00033553·Anniston, Alabama and 73 others

CompletedPhase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV DiseasePRIMARY: To compare the frequency of and time to relapse of Cytomegalovirus (CMV) gastrointestinal disease following foscarnet induction therapy only versus induction plus…NCT00002145·Berkeley, California and 14 others

CompletedPeripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)The study is designed as a Phase III, randomized, open label, multicenter, prospective, comparative trial of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral…NCT00075816·Birmingham, Alabama and 44 others

CompletedSafety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3The primary objective of this study is to evaluate the safety and tolerability of GS-4997 (selonsertib \[SEL\]) alone or in combination with simtuzumab (SIM) in adults with…NCT02466516·Palo Alto, California and 27 others

Active not recruitingPlacebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)Researchers are looking for new ways to treat Limited-Stage Small Cell Lung Cancer (LS-SCLC), a type of lung cancer that has not spread from the lung to other parts of the body.NCT04624204·Chandler, Arizona and 186 others

UnknownSafety and Effectiveness of Cortical Stimulation in the Treatment of Stroke Patients With Upper Extremity HemiparesisThe purpose of this study is to assess the safety and effectiveness of cortical stimulation delivered concurrent with rehabilitation activities to enhance motor recovery in…NCT00170716·Tucson, Arizona and 20 others

CompletedC2P - Phase III: MPowerment and Community PromiseOne of the objectives of the C2P coalition is the successful delivery of a CDC-endorsed community-level HIV prevention program aimed at changing the risk profiles of youth.NCT00381784·Los Angeles, California and 6 others

Active not recruitingTwo Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialThis phase III trial uses the Decipher risk score to guide therapy selection.NCT05050084·Birmingham, Alabama and 575 others

CompletedEZN-2279 in Patients With ADA-SCIDThe purpose of this study is to evaluate the safety, efficacy, and pharmacokinetics of EZN-2279 in patients with ADA-deficient combined immunodeficiency currently being treated…NCT01420627·Los Angeles, California and 5 others

PreviousPage 124 of 261Next

Diabetes

in San Francisco

Heart Diseasein San Francisco